Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1Phase 1 1

Status

Unknown 11Recruiting 11Not yet recruiting 7Completed 5Active not recruiting 4Terminated 3Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 2678Pancreatic Neoplasms 1470Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1127Rectal Neoplasms 980Esophageal Neoplasms 728Neoplasms 559Liver Neoplasms 533Breast Neoplasms 473Neoplasm Metastasis 373Lung Neoplasms 325Carcinoma, Non-Small-Cell Lung 292Gastrointestinal Neoplasms 277Ovarian Neoplasms 258Prostatic Neoplasms 229Cholangiocarcinoma 221Head and Neck Neoplasms 180Gastrointestinal Stromal Tumors 176Melanoma 165Esophageal Squamous Cell Carcinoma 164Barrett Esophagus 156Uterine Cervical Neoplasms 151Biliary Tract Neoplasms 149Adenocarcinoma Of Esophagus 148Gallbladder Neoplasms 136Carcinoma, Renal Cell 134Urinary Bladder Neoplasms 132Sarcoma 131Anus Neoplasms 124

Interventions

trifluridine tipiracil drug combination 1tipiracil 1Trifluridine 1Taxes 1Irinotecan 1Gastrectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Gastric Adenocarcinoma × Gastrointestinal × Clear all
NCT06614439 2025-11-18

PG Versus TG for Advanced PGC

National Taiwan University Hospital

Phase NA Completed
96 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT06690268 2024-11-15

FUTURE12

Hebei Medical University

Completed
93 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT04074343 2024-02-02

TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

University of California, Irvine

Phase 1 Completed
20 enrolled 9 charts
Gastrointestinal

Gastric Adenocarcinoma

NCT02801955 2017-06-14

Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma

Bezmialem Vakif University

Completed
67 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT01336062 2015-05-19

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

Peking University

Phase 1/2 Completed
19 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡